BW

Benson Hill Appoints Richard Mack to Board of Directors

Agriculture Industry Executive Brings Nearly Three Decades of Experience to Benson Hill BoardST. LOUIS--(BUSINESS WIRE)--$BHIL #BHIL--Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), a food tech company unlocking the natural genetic diversity of plants, today announced that it has appointed Richard Mack as an Independent Director to the…
Leer más...

nLIGHT Announces Participation in 15th Annual CEO Investor Summit

CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power semiconductor and fiber lasers used in the industrial, microfabrication, and aerospace and defense markets, today announced management’s participation in the 15th Annual CEO Investor Summit, being held Wednesday, July 12th, 2023, at the St. Regis San Francisco. The investor…
Leer más...

Origin Materials Announces Chief Financial Officer Transition

CFO Nate Whaley to remain at Origin through September 1 and hold advisory role through end of year to ensure a smooth transition to successorWEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (NASDAQ: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to…
Leer más...

Benson Hill Announces Leadership Transition

Adrienne “Deanie” Elsner Appointed Interim Chief Executive Officer, Effective Immediately Matt Crisp Resigning as Chief Executive OfficerST. LOUIS--(BUSINESS WIRE)--$BHIL #BHIL--Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), a food tech company unlocking the natural genetic diversity of plants, today announced that Adrienne “Deanie” Elsner has been appointed Interim…
Leer más...

Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio

BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as…
Leer más...

KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Met Primary Endpoint of Progression-Free Survival as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinomaRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase…
Leer más...

Pablo Castaños Joins Golden Minerals as Executive Vice President

GOLDEN, Colo.--(BUSINESS WIRE)--$AUMN #gold--Golden Minerals Company (“Golden Minerals,” “Golden” or the “Company”) (NYSE American: AUMN and TSX: AUMN) is pleased to announce that Pablo Castaños will be joining the Company on July 1, 2023, serving in a newly-created role of executive vice president. Mr. Castaños brings to the Company more…
Leer más...

Ault Alliance Announces an Initial Partial Distribution of TOG Securities of Approximately $2.12 for each share of Ault Alliance Common Stock

Ault Alliance will Distribute 40 Shares of Common Stock and Warrants to Purchase 40 Shares of Common Stock of Imperalis Holding Corp., with a Record Date of June 26, 2023LAS VEGAS--(BUSINESS WIRE)--$AGREE #AGREE--Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company, (“Ault Alliance” or the “Company”), hereby announces an…
Leer más...